Stable polymorph of N- (3-ethynylphenyl)-6,7-bis(2-methoxyeth oxy)-4-quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereof

Details for Australian Patent Application No. 2006201815 (hide)

Owner OSI Pharmaceuticals, Inc.

Inventors Ferrante, Karen, J; Raggon, Jeffrey, W; Kajiji, Shama, M; Norris, Timothy; Moyer, James, D; Silberman, Sandra, L; Foster, Barbara, A; Morin, Michael, J; Connell, Richard, D

Agent Davies Collison Cave

Pub. Number AU-B-2006201815

Parent 784243

Filing date 1 May 2006

Wipo publication date 25 May 2006

Acceptance publication date 1 October 2009

International Classifications

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

C07D 239/94 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

Event Publications

18 May 2006 Complete Application Filed

25 May 2006 Application Open to Public Inspection

  Published as AU-B-2006201815

1 October 2009 Application Accepted

  Published as AU-B-2006201815

28 January 2010 Standard Patent Sealed

11 February 2010 Licence Registered

  OSI Pharmaceuticals, Inc. ( F. Hoffmann-La Roche Ltd. )

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006201816-Positioning cap for hinge assembly

2006201814-Method of manufacturing a driveshaft assembly